RTX Corp: Form 10-K for the period ended Dec 31, 2017
Filed with the SEC on Feb 9, 2018 and accepted by EDGAR at Feb 8, 2018, 19:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2017-01-01 to 2017-12-31 | $31.03bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2017-10-01 to 2017-12-31 | $3.95bn | us-gaap:GrossProfit |
| Research and development | 12 months2017-01-01 to 2017-12-31 | $2.39bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2017-01-01 to 2017-12-31 | $6.18bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2017-01-01 to 2017-12-31 | $8.67bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2017-01-01 to 2017-12-31 | $909.0m | us-gaap:InterestExpense |
| Income tax | 12 months2017-01-01 to 2017-12-31 | $2.84bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-10-01 to 2017-12-31 | $397.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2017-01-01 to 2017-12-31 | $4.55bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-10-01 to 2017-12-31 | $0.50 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2017-01-01 to 2017-12-31 | $5.70 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-10-01 to 2017-12-31 | $0.50 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2017-01-01 to 2017-12-31 | $5.76 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2017-01-01 to 2017-12-31 | 799,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2017-01-01 to 2017-12-31 | $5.63bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2017-01-01 to 2017-12-31 | $2.01bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2017-01-01 to 2017-12-31 | $2.07bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2017-01-01 to 2017-12-31 | $1.45bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $8.98bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $32.86bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $96.92bn | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $24.39bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $65.37bn | us-gaap:Liabilities |
| Long-term debt | At period end2017-12-31 | $27.09bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2017-12-31 | $392.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2017-12-31 | $29.61bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000101829-18-000005. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.